MRCP UK EXAMINATIONS

Detailed explanation-1: -[3] Terbutaline is a commonly used short-acting beta-2 agonist as a tocolytic in the cessation of labor contractions. LABAs are used in treatment for patients with asthma and COPD, often in conjunction with inhaled corticosteroids.

Detailed explanation-2: -Albuterol/budesonide inhaled (Airsupra) It is the first combination of an inhaled corticosteroid (ICS) and a short-acting beta-agonist to be approved in the U.S. Additionally, it is the first product containing an ICS to be approved in the U.S. as a reliever treatment (rather than as a controller) for asthma.

Detailed explanation-3: -The short-acting beta2 agonists (albuterol, levalbuterol, metaproterenol, and pirbuterol) are used for the treatment or prevention of bronchospasm. These medications are typically delivered to the bronchial smooth muscles through inhalation of aerosolized or nebulized preparations of these medications.

Detailed explanation-4: -Inhaled, short-acting, selective beta-2 adrenergic agonists are the traditional mainstay of acute asthma therapy, while inhaled, long-acting, selective beta-2 adrenergic agonists (in combination with inhaled glucocorticoids) play a role in long-term control of moderate to severe asthma [1].

Detailed explanation-5: -Salmeterol (Serevent®). Formoterol (Foradil®). Combination medications, including fluticasone and salmeterol (Advair®), budesonide and formoterol (Symbicort®) and fluticasone and vilanterol (Breo®). 09-Aug-2022